{"DataElement":{"publicId":"2900116","version":"3","preferredName":"Malignant Neoplasm Clinical Information Group Histologic Grade","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication.:Any number of entities (members) considered as a unit._Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth_Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A position on a scale of intensity or amount or quality.","longName":"2899858v1.0:2785835v1.2","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"2899858","version":"1","preferredName":"Malignant Neoplasm Clinical Information Group Grade","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication.:Any number of entities (members) considered as a unit._Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"2899675v1.0:2427327v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"2899675","version":"1","preferredName":"Malignant Neoplasm Clinical Information Group","preferredDefinition":"A tumor composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas (adenocarcinomas or squamous cell carcinomas), Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.:Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.:Knowledge derived from study, experience, or instruction that has been gathered or received by communication.:Any number of entities (members) considered as a unit.","longName":"C9305:C25398:C48191:C43359","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Malignant Neoplasm","conceptCode":"C9305","definition":"A neoplasm composed of atypical neoplastic, often pleomorphic cells that invade other tissues. Malignant neoplasms often metastasize to distant anatomic sites and may recur after excision. The most common malignant neoplasms are carcinomas, Hodgkin and non-Hodgkin lymphomas, leukemias, melanomas, and sarcomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Information","conceptCode":"C48191","definition":"Knowledge derived from study, experience, or instruction that has been gathered or received by communication.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Group","conceptCode":"C43359","definition":"Any number of entities (members) considered as a unit.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C028EDB-BEA0-1E31-E040-BB89AD43106F","latestVersionIndicator":"Yes","beginDate":"2009-06-10","endDate":null,"createdBy":"UMLLOADER_IMAGEMINER","dateCreated":"2009-06-10","modifiedBy":"ONEDATA","dateModified":"2009-06-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2427327","version":"1","preferredName":"Grade","preferredDefinition":"Describes how closely a cancer resembles normal tissue of its same type, and the cancer's probable rate of growth","longName":"C18000","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"05116195-EBA8-7341-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-09","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-09","modifiedBy":"ONEDATA","dateModified":"2005-11-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2222502","version":"1","preferredName":"UML DEFAULT CD","preferredDefinition":"Default Conceptual Domain for UML Loader","longName":"UML DEFAULT CD","context":"caCORE","contextVersion":"1","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F5E53F3B-47A4-52D1-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-29","endDate":null,"createdBy":"SBREXT","dateCreated":"2005-04-29","modifiedBy":"DWARZEL","dateModified":"2021-04-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6C02A42D-1234-EE7F-E040-BB89AD4331A9","latestVersionIndicator":"Yes","beginDate":"2009-06-10","endDate":null,"createdBy":"UMLLOADER_IMAGEMINER","dateCreated":"2009-06-10","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"1/1/11 Released as part of ImageMiner model cleanup.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2785835","version":"1.2","preferredName":"Histologic Grade","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues._A position on a scale of intensity or amount or quality.","longName":"HIST_GD","context":"NCI Standards","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"14","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intermediate Grade","valueDescription":"Intermediate Grade","ValueMeaning":{"publicId":"3335158","version":"1","preferredName":"Intermediate Grade","longName":"3335158","preferredDefinition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.\r\n","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Intermediate Grade","conceptCode":"C28083","definition":"A term referring to the degree of differentiation of a malignant neoplasm and indicating that it is moderately differentiated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B43D00DA-4E4B-7AC2-E040-BB89AD434B8C","latestVersionIndicator":"Yes","beginDate":"2011-12-16","endDate":null,"createdBy":"ZHANGW","dateCreated":"2011-12-16","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"8C149354-7625-64FC-E053-F662850AE4E2","beginDate":"2019-06-24","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2019-06-24","modifiedBy":"ONEDATA","dateModified":"2019-06-24","deletedIndicator":"No"},{"value":"G2","valueDescription":"Moderately Differentiated","ValueMeaning":{"publicId":"2559269","version":"1","preferredName":"Moderately Differentiated","longName":"2559269v1.00","preferredDefinition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Moderately Differentiated","conceptCode":"C14162","definition":"Describes tumor cells that have lost some of the appearance of normal cells. They tend to grow and spread at a faster rate than well differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B492-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D165-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Low Grade","valueDescription":"Low Grade","ValueMeaning":{"publicId":"3288210","version":"1","preferredName":"Low Grade","longName":"3288210","preferredDefinition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade","conceptCode":"C14161","definition":"Used to describe tumor samples that exhibit well to moderately well differentiated cells. They are generally expected to be slow growing and less aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B13C-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D16F-725E-E053-F662850AB0CE","beginDate":"2013-02-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"High Grade","valueDescription":"High Grade","ValueMeaning":{"publicId":"3288211","version":"1","preferredName":"High Grade","longName":"3288211","preferredDefinition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade","conceptCode":"C14158","definition":"Used to describe tumor samples that exhibit poorly differentiated or undifferentiated cells. They are generally expected to be fast growing and aggressive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"AE6DC488-B15F-8FD1-E040-BB89AD432EE0","latestVersionIndicator":"Yes","beginDate":"2011-10-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-10-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D179-725E-E053-F662850AB0CE","beginDate":"2013-02-12","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"G1","valueDescription":"Well Differentiated","ValueMeaning":{"publicId":"3685458","version":"1","preferredName":"Well Differentiated","longName":"3685458v1.00","preferredDefinition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Well Differentiated","conceptCode":"C14171","definition":"Describes tumor cells that generally retain the appearance of normal cells and tend to grow and spread at a slower rate than undifferentiated or poorly differentiated tumor cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A18-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D183-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"G4","valueDescription":"Undifferentiated Histology","ValueMeaning":{"publicId":"2560389","version":"1","preferredName":"Undifferentiated Histology","longName":"2560389v1.00","preferredDefinition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B8F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D197-725E-E053-F662850AB0CE","beginDate":"2008-09-19","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"G3","valueDescription":"Poorly Differentiated","ValueMeaning":{"publicId":"3685459","version":"1","preferredName":"Poorly Differentiated","longName":"3685459","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A3B-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D18D-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"GB","valueDescription":"Borderline Histologic Grade","ValueMeaning":{"publicId":"3685460","version":"1","preferredName":"Borderline Histologic Grade","longName":"3685460","preferredDefinition":"Straddling the dividing line between two categories.: The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Borderline","conceptCode":"C14157","definition":"Straddling the dividing line between two categories.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D58D9008-3A6B-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2013-02-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D1A1-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"GX","valueDescription":"Grade Cannot be Assessed","ValueMeaning":{"publicId":"3685461","version":"1","preferredName":"Grade Cannot be Assessed","longName":"3685461","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: Having determined the value, significance, or extent of.: The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Assessment","conceptCode":"C25217","definition":"The final result of a determination of the value, significance, or extent of.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histologic Grade","conceptCode":"C18000","definition":"The degree of abnormality of cancer cells, a measure of differentiation, the extent to which cancer cells are similar in appearance and function to healthy cells of the same tissue type. The degree of differentiation often relates to the clinical behavior of the particular tumor. Based on the microscopic findings, tumor grade is commonly described by one of four degrees of severity. Histopathologic grade of a tumor may be used to plan treatment and estimate the future course, outcome, and overall prognosis of disease. Certain types of cancers, such as soft tissue sarcoma, primary brain tumors, lymphomas, and breast have special grading systems.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"D58DFA07-74C5-5942-E040-BB89AD4372FC","latestVersionIndicator":"Yes","beginDate":"2013-02-12","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"COOPERM","dateModified":"2013-02-12","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D1AB-725E-E053-F662850AB0CE","beginDate":"2008-09-18","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5043360","version":"1","preferredName":"Not Applicable","longName":"5043360","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2421E11B-65A6-151D-E050-BB89AD4378BB","latestVersionIndicator":"Yes","beginDate":"2015-11-09","endDate":null,"createdBy":"REEVESD","dateCreated":"2015-11-09","modifiedBy":"DWARZEL","dateModified":"2018-10-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"89F3FEE8-D1B5-725E-E053-F662850AB0CE","beginDate":"2019-04-09","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"ONEDATA","dateModified":"2019-05-28","deletedIndicator":"No"},{"value":"Not Reported","valueDescription":null,"ValueMeaning":{"publicId":"5612322","version":"1","preferredName":"Not Reported","longName":"5612322v1.00","preferredDefinition":"Not provided or available.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Reported","conceptCode":"C43234","definition":"Not provided or available.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"45340835-3B00-7C78-E053-F662850A44F9","latestVersionIndicator":"Yes","beginDate":"2017-01-03","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-01-03","modifiedBy":"FINCHAMB","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"10/10/23 changed Long Name from \"Not Stated\" to match NCIt Preferred name and current caDSR concept Long Name of \"Not Reported\" per Brenda.Janice . LS","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"097FBB3F-C7B2-6402-E063-731AD00A7379","beginDate":"2023-11-06","endDate":null,"createdBy":"CLOHNES","dateCreated":"2023-11-06","modifiedBy":"CLOHNES","dateModified":"2023-11-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2786701","version":"1","preferredName":"Histologic Grade","preferredDefinition":"Of or relating to histology.:A position on a scale of intensity or amount or quality.","longName":"C25526:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"57451CD6-05F6-28B9-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-19","endDate":null,"createdBy":"REEVESD","dateCreated":"2008-09-19","modifiedBy":"ONEDATA","dateModified":"2008-09-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"89F3FEE8-D150-725E-E053-F662850AB0CE","latestVersionIndicator":"Yes","beginDate":"2019-05-28","endDate":null,"createdBy":"ZHANGWE","dateCreated":"2019-05-28","modifiedBy":"CLOHNES","dateModified":"2023-11-06","changeDescription":"5/28/2019 added new version due to max length changes, wz.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2899621","version":"1","longName":"ImageMiner","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2899635","version":"1","longName":"org.imageminer.domain.tma.dynamic","context":"NCIP"},{"publicId":"2899634","version":"1","longName":"TMAMiner","context":"NCIP"}]}],"AlternateNames":[{"name":"CancerClinicalPanel:histologicGrade","type":"UML Class:UML Attr","context":"NCIP"},{"name":"org.imageminer.domain.tma.dynamic.CancerClinicalPanel.histologicGrade","type":"UML Qualified Attr","context":"NCIP"},{"name":"SWOG","type":"USED_BY","context":"SWOG"},{"name":"HISTOLGRD","type":"OID, SWOG","context":"SWOG"}],"ReferenceDocuments":[{"name":"Data Element Malignant Neoplasm Clinical Information Group Histologic Grade does not have Preferred Question Text","type":"Preferred Question Text","description":"Data Element Malignant Neoplasm Clinical Information Group Histologic Grade does not have Preferred Question Text","url":null,"context":"NCIP"},{"name":"Histologic grade","type":"Alternate Question Text","description":"Histologic grade","url":null,"context":"SWOG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"968E7FC0-90EF-32D6-E053-F662850A083B","latestVersionIndicator":"Yes","beginDate":"2019-11-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2019-11-04","modifiedBy":"COOPERM","dateModified":"2019-11-04","changeDescription":"1/1/11 Released as part of ImageMiner model cleanup 7/25/13 Versioned CDE to reuse versioned VD.  Retired old CDE. mc 11/4/19 Versioned CDE to reuse versioned VD.  Retired old CDE. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}